FIGURE 2.
The patient obtained excellent response with anti-IL12/23 and lamivudine in a two year follow-up with no adverse effects
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.